BTA
Click for more information
0.00% 57.0¢ biota holdings limited

sues gsk for failure to support its influenza drug, page-9

  1. phil_latio
    219 Posts.
    clock Created with Sketch.
    11/05/04
    06:57
    Post #: 463205
    re: sues gsk article.. smh today could simply be a ploy to get back the IP rights for Relenza. It is unlikely Glaxo will cough up hard cash, they could hold it up in the courts for years before BTA gets a penny....
    BTA Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MND Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
right-arrow Created with Sketch.
LML Lincoln repositions Kookaburra for low-cost graphite delivery
right-arrow Created with Sketch.
TG1 TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
right-arrow Created with Sketch.
STX Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
right-arrow Created with Sketch.
WCN White Cliff wraps up Canadian fieldwork programs – 'visually confirming' a slew of minerals
right-arrow Created with Sketch.
POL Polymetals finalises acquisition of Endeavor silver-lead-zinc mine in NSW's Cobar Basin
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.